BACKGROUND: Stenotrophomonas maltophilia is a significant nosocomial pathogen,
responsible for an increasing number of infections, particularly in immunocompromised …

Objective: Stenotrophomonas maltophilia is an important nosocomial pathogen and a
therapeutic challenge. A ten-year review of episodes of bacteraemia due to S. maltophilia …

BACKGROUND: Stenotrophomonas maltophilia has emerged as a significant nosocomial
pathogen with increasing resistance to trimethoprim/sulphamethoxazole (TMP/SMX), the …

Stenotrophomonas maltophilia is an important nosocomial pathogen with intrinsic multi-drug
resistance. This retrospective study reviewed 84 episodes of S. maltophilia bacteremia over …

Stenotrophomonas maltophilia is an emerging nosocomial pathogen with a tendency to be
resistant to several antibiotics commonly used to treat nosocomial infections. Early …

Severe infections caused by Stenotrophomonas maltophilia are associated with high
mortality, and strategies to improve the clinical outcome for infected patients are needed. A …

Stenotrophomonas maltophilia is an important nosocomial pathogen with increasing
frequency in recent years, especially in immunocompromised and clinically debilitated …

Stenotrophomonas maltophilia is a significant pathogen that primarily affects patients with co-
morbid illnesses, usually malignancies, who have been hospitalized for prolonged periods …

Stenotrophomonas maltophilia is an important nosocomial pathogen, especially among
immunocompromised patients. The objective of this study was to clarify the clinical …

Background. Stenotrophomonas maltophilia bacteremia (SMB) is the most perilous situation
as compared to other types of S. maltophilia infection. The present study aimed to …